Ind-Swift gets renewed approval for Global Business Unit

30 May 2025 Evaluate

Ind-Swift has received renewed approval for its 100% Export Oriented Unit (Global Business Unit (GBU)) situated at Punjab for a period of three years from Medicines & Healthcare Products Regulatory Agency (MHRA), London, United Kingdom. The approval is based on the assessment undertaken by the agency of company’s quality metrics and quality systems.

Ind-Swift is Chandigarh based pharmaceutical company, established in 1986 with a mission of winning global customers through innovative pharmaceutical products.

Ind-Swift - Amalgama Share Price

15.70 0.00 (0.00%)
13-Aug-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×